Skip to main content
. 2021 Aug 27;10(9):2218. doi: 10.3390/cells10092218

Figure 1.

Figure 1

Higher levels of PLEC mRNA expression are associated with poor ovarian cancer patient survival. (A,B) The KM plotter database was used to evaluate the prognostic value of PLEC mRNA expression in OC’s most common subtype, TP53 mutant serous carcinoma. High PLEC expression is a significant indicator of (A) overall survival and (B) post-progression survival in this subset of patients. (C) A differential expression analysis using Oncomine revealed PLEC to be significantly overexpressed in OC tissues.